BioCentury
ARTICLE | Company News

EC approves MediGene's Oracea

July 30, 2008 1:47 AM UTC

The EC approved Oracea doxycycline from MediGene (Xetra:MDG) to treat rosacea. MediGene, which decided in June to exit dermatology to focus on cancer and autoimmune products, is negotiating with poten...